ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants
Portfolio Pulse from Benzinga Newsdesk
ICL and Lavie Bio have made significant advancements in developing bio-stimulants for crops facing extreme weather conditions by leveraging AI. Lavie Bio identified over a dozen novel microbes with commercial potential within 12 months using their proprietary technology.

July 17, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evogene's subsidiary, Lavie Bio, has identified over a dozen novel microbial candidates for bio-stimulants using AI, marking a significant milestone in their collaboration with ICL.
Lavie Bio's use of AI to identify novel microbial candidates for bio-stimulants within a short timeframe demonstrates the effectiveness of their technology platform. This progress is likely to enhance Evogene's market position and revenue potential.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
ICL, a global specialty minerals company, has made significant progress in developing bio-stimulants for crops facing extreme weather conditions through its collaboration with Lavie Bio.
ICL's collaboration with Lavie Bio has led to the identification of novel microbes that can be used as bio-stimulants, potentially increasing crop yields under extreme weather conditions. This advancement is likely to positively impact ICL's revenue and market position.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80